Handheld ultrasound + AI could bring breast cancer screening to remote areas

NCT ID NCT06932133

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a low-cost, portable ultrasound device (POCUS) combined with artificial intelligence to detect breast cancer in women with suspicious symptoms. The goal is to see if this approach works as well as standard imaging, especially in places where expensive equipment is not available. About 600 women will take part, and the study will also check how well the AI can analyze the ultrasound images on its own.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Unilabs Mammography Unit, Skane University Hospital

    Malmö, 20502, Sweden